HRT FINANCIAL LP

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1475597 NEW YORK, NY

Position in TEVA

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$4,223,486

+$3,825,091 QoQ

Shares Held

140,222

+998.5% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $86,437,876 across 27 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	66,842	$39,635,969
2	HLN	Haleon plc	1,100,190	$11,012,901
3	HIMS	Hims & Hers Health, Inc.	284,622	$5,908,752
4	TEVA	Teva Pharmaceutical Industries Ltd This page	140,222	$4,223,486
5	NBIX	Neurocrine Biosciences Inc	26,404	$3,478,462
6	LQDA	Liquidia Corp	86,687	$3,271,567
7	ALKS	Alkermes plc.	81,989	$2,899,131
8	TAK	Takeda Pharmaceutical Co Ltd	126,074	$2,334,890

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,223,486	140,222	+998.5%	Shares	Defined	2026-05-14
2025-12-31	$398,395	12,765	-61.0%	Shares	Defined	2026-02-12
2023-09-30	$333,652	32,711	-25.6%	Shares	Defined	2023-11-13
2023-06-30	$331,214	43,986	+42.1%	Shares	Defined	2023-08-11
2023-03-31	$273,987	30,959	-10.1%	Shares	Defined	2023-05-12
2022-06-30	$258,891	34,427	+32.7%	Shares	Defined	2022-08-12
2021-06-30	$256,845	25,944	-25.5%	Shares	Defined	2021-08-16
2021-03-31	$401,695	34,809	+86.3%	Shares	Defined	2021-05-17
2020-12-31	$180,329	18,687	+16.0%	Shares	Defined	2021-02-16
2020-03-31	$144,622	16,105	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.